1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis pilot program provides diapers at no cost to eligible families in Maricopa County, Arizona. It is funded through a grant from the U. S.
Department of Health and Human Services (HHS) via Wildfire, the Community Action Association (CAA) for Arizona.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible families in Maricopa County, Arizona, through MCHSD Early Education (EDD) and Community Services (CSD) programs. Confirm the full requirements in the official notice before applying.
The current listing shows approximately $75 worth of diapers per month for up to 12 months per eligible family. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Diaper Grant (Maricopa County) is funded by Maricopa County Human Services Department (MCHSD). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read article